What is LOPJLB’s current signal on ASMB?

LOPJLB’s latest quantitative signal on Assembly Biosciences, Inc. (ASMB) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is ASMB in?

Assembly Biosciences, Inc. (ASMB) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does Assembly Biosciences, Inc. (ASMB) do?

Assembly Biosciences, Inc. is a biotechnology firm in the clinical development phase, dedicated to identifying and advancing innovative therapeutic solutions for hepatitis B virus (HBV) infections within the United States. Its primary drug candidate, Vebicorvir, has successfully concluded Phase 2 clinical trials for individuals with chronic HBV. The company's development pipeline also features …

Where is Assembly Biosciences, Inc. based / listed?

Assembly Biosciences, Inc. is based in US, listed on NASDAQ.

Assembly Biosciences, Inc. (ASMB)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$22.82-0.57%Close

SELLCRISIS · day 21

RANGE

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONEBEST

Key stats

Short interest · FINRA settlement 2026-09-15

Market cap: $363M
Beta: 1.13
P/E (TTM): 40.33

Short % float: 24.38%
Days to cover: 6.3
SI change: -1.2%

1W: -0.70%
1M: -30.57%

vs SPY 1W: -2.25%
vs SPY 1M: -32.34%

Industry peers

FMP comparable companies · ranked by market cap

VIRBUYVir Biotechnology, Inc.$2.0BRECOVERYQ 13$11.60-3.47%
ABUSSELLArbutus Biopharma Corp$885MCRISISQ 13$4.48-2.56%

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Key stats

Industry peers

Prediction markets

Company news